These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8158003)

  • 1. Efficient transfer of antibodies into mammalian cells by electroporation.
    Lukas J; Bartek J; Strauss M
    J Immunol Methods; 1994 Apr; 170(2):255-9. PubMed ID: 8158003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to mammalian D-type G1 cyclins.
    Vallance SJ; Lee HM; Roussel MF; Shurtleff SA; Kato JY; Strom DK; Sherr CJ
    Hybridoma; 1994 Feb; 13(1):37-44. PubMed ID: 8200657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.
    Lukas J; Bartkova J; Welcker M; Petersen OW; Peters G; Strauss M; Bartek J
    Oncogene; 1995 Jun; 10(11):2125-34. PubMed ID: 7784057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.
    Lukas J; Pagano M; Staskova Z; Draetta G; Bartek J
    Oncogene; 1994 Mar; 9(3):707-18. PubMed ID: 8108113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.
    Bartkova J; Lukas J; Strauss M; Bartek J
    Oncogene; 1998 Aug; 17(8):1027-37. PubMed ID: 9747882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 is required for S phase traversal in bovine tracheal myocytes.
    Xiong W; Pestell RG; Watanabe G; Li J; Rosner MR; Hershenson MB
    Am J Physiol; 1997 Jun; 272(6 Pt 1):L1205-10. PubMed ID: 9227524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the prognostic value of cyclin D1 overexpression in breast cancer.
    McIntosh GG; Anderson JJ; Milton I; Steward M; Parr AH; Thomas MD; Henry JA; Angus B; Lennard TW; Horne CH
    Oncogene; 1995 Sep; 11(5):885-91. PubMed ID: 7675447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
    Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D
    Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein.
    Bartkova J; Lukas J; Strauss M; Bartek J
    J Pathol; 1994 Mar; 172(3):237-45. PubMed ID: 8195927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin E-induced S phase without activation of the pRb/E2F pathway.
    Lukas J; Herzinger T; Hansen K; Moroni MC; Resnitzky D; Helin K; Reed SI; Bartek J
    Genes Dev; 1997 Jun; 11(11):1479-92. PubMed ID: 9192874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of defective mitogenic signaling by D-type cyclins.
    Roussel MF; Theodoras AM; Pagano M; Sherr CJ
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6837-41. PubMed ID: 7624328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cdk2 kinase is required for the G1-to-S transition in mammalian cells.
    Tsai LH; Lees E; Faha B; Harlow E; Riabowol K
    Oncogene; 1993 Jun; 8(6):1593-602. PubMed ID: 8502482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.
    Musgrove EA; Lee CS; Buckley MF; Sutherland RL
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8022-6. PubMed ID: 8058751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Threshold expression of cyclin E but not D type cyclins characterizes normal and tumour cells entering S phase.
    Gong J; Traganos F; Darzynkiewicz Z
    Cell Prolif; 1995 Jun; 28(6):337-46. PubMed ID: 7626688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of antibody into viable cells using electroporation.
    Berglund DL; Starkey JR
    Cytometry; 1991; 12(1):64-7. PubMed ID: 1999124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.